Intravenous nanocrystals: fabrication, solidification, in vivo fate, and applications for cancer therapy

IntroductionIntravenous nanocrystals (INCs) have shown intrinsic advantages in antitumor applications, particularly their properties of high drug loading, low toxicity, and controllable size. Therefore, it has a very bright application prospect as a drug delivery system.Areas coveredThe ideal formulation design principles, fabrication, solidification, in vivo fate of INCs, the applications in drug delivery system (DDS) and the novel applications are covered in this review.Expert opinionIt is vital to select a suitable formulation and fabrication method to produce a stable and sterile INCs. Besides, the type of stabilizers and physical characteristics can also influence the in vivo fate of INCs, which is worthy of further studying. Based on wide researches about applications of INCs in cancer, biomimetic INCs are concerned increasingly for its favorable compatibility. The output of these studies suggested that INCs-based drug delivery could be a novel strategy for addressing the delivery of the drug that faces solubility, bioavailability, and toxicity problems.

Automated summary

Intravenous nanocrystals (INCs) have intrinsic advantages in antitumor applications due to their high drug loading, low toxicity, and controllable size. The selection of a suitable formulation and fabrication method is vital for the production of stable and sterile INCs. The type of stabilizers and physical characteristics can influence the in vivo fate of INCs, which is worth further investigation. Biomimetic INCs are gaining increasing attention for their favorable compatibility, and INCs-based drug delivery shows potential as a novel strategy for addressing solubility, bioavailability, and toxicity issues.